Jingwei Li

机构：Affiliated Hospital of Shandong University of Traditional Chinese Medicine · ORCID：0000-0001-5864-7307

发表论文 35 篇 · 总被引 243 次 · h-index 8

代表论文

• CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization (2024 · Cell Death and Differentiation · 被引 42)
• Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review (2022 · European journal of medical research · 被引 33)
• The adverse events of CDK4/6 inhibitors for HR+/ HER2- breast cancer: an umbrella review of meta-analyses of randomized controlled trials (2024 · Frontiers in Pharmacology · 被引 20)
• β-eudesmol inhibits cell proliferation and induces ferroptosis via regulating MAPK signaling pathway in breast cancer (2023 · Toxicon · 被引 14)
• Recent advances in nanoparticle-enhanced clean VES fracturing fluids: a comprehensive review of performance improvement, synergy, and challenges (2025 · Chemical Engineering Science · 被引 9)
• Rare and Complicated Granulomatous Lobular Mastitis (2000–2023): A Bibliometrics Study and Visualization Analysis (2024 · Journal of Inflammation Research · 被引 9)